The Hominis Surgical System developed by Memic Innovative Surgery is a robotic surgical device (Courtesy)
Memic Innovative Surgery, a medical device company, said it has received marketing authorization from the US Food and Drug Administration for a robotic surgical device it has developed to perform transvaginal hysterectomies in patients.
The Hominis Surgical System developed by Memic features miniature humanoid-shaped robotic arms. It is intended for benign hysterectomy, or the removal of the uterus for non-cancerous conditions along with the removal of one or both fallopian tubes and ovaries.
“We are providing physicians and patients another minimally-invasive gynecologic surgical option for non-cancerous conditions,” said Dr. Binita Ashar, director of the Office of Surgical and Infection Control Devices in the FDA’s Center for Devices and Radiological Health, in a statement on March 1. “The FDA continues to support advancements in safe and effective medical devices that can improve patient experiences when undergoing surgical procedures.”